These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24827374)

  • 21. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
    Maddox TM; Borden WB; Tang F; Virani SS; Oetgen WJ; Mullen JB; Chan PS; Casale PN; Douglas PS; Masoudi FA; Farmer SA; Rumsfeld JS
    J Am Coll Cardiol; 2014 Dec; 64(21):2183-92. PubMed ID: 25447259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective Evaluation of ASCVD Risk and Statin Therapy Need in Nondiabetic Patients Based on the 2013 ACC/AHA Cholesterol Guidelines.
    Koenigsfeld C; Sayler M; Smith HL; Meyer K; Lehman N; Logemann C; Bottenberg M; Bryant G; Obermark M
    J Pharm Pract; 2017 Jun; 30(3):300-305. PubMed ID: 27026635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology Position Statement on Dyslipidemia Management. Differences Between the European and American Guidelines].
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
    Hipertens Riesgo Vasc; 2015; 32(2):83-91. PubMed ID: 26179969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin Eligibility and Outpatient Care Prior to ST-Segment Elevation Myocardial Infarction.
    Miedema MD; Garberich RF; Schnaidt LJ; Peterson E; Strauss C; Sharkey S; Knickelbine T; Newell MC; Henry TD
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28404560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
    Pavlovic J; Greenland P; Deckers JW; Brugts JJ; Kavousi M; Dhana K; Ikram MA; Hofman A; Stricker BH; Franco OH; Leening MJ
    JAMA Cardiol; 2016 Sep; 1(6):708-13. PubMed ID: 27439175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Merits and potential downsides of the 2013 ACC/AHA cholesterol management guidelines.
    Gotto AM; Moon JE
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):573-6. PubMed ID: 24819819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 2013 American College of Cardiology/American Heart Association guidelines on treating blood cholesterol and assessing cardiovascular risk: a busy practitioner's guide.
    Gupta A; Smith DA
    Endocrinol Metab Clin North Am; 2014 Dec; 43(4):869-92. PubMed ID: 25432387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of the American College of Cardiology/American Heart Association guidelines for the treatment of blood cholesterol for a rural community: Data from the Heart of New Ulm Project.
    Miedema MD; Sidebottom AC; Sillah A; Benson G; Knickelbine T; VanWormer JJ
    J Clin Lipidol; 2017; 11(1):94-101. PubMed ID: 28391916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compliance With Dyslipidemia Guidelines in Daily Practice: How Effective Is Cardiovascular Risk Prevention?
    Güntekin Ü; Gümrükçüoğlu HA; Yaman M; Öztürk F; Akyol A; Gümrükçüoğlu FN; Okudan YE; Tosun V; Kandemir YB
    Clin Ther; 2018 Dec; 40(12):2031-2040. PubMed ID: 30392816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines.
    Cainzos-Achirica M; Desai CS; Wang L; Blaha MJ; Lopez-Jimenez F; Kopecky SL; Blumenthal RS; Martin SS
    Mayo Clin Proc; 2015 Sep; 90(9):1262-71. PubMed ID: 26269108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
    ; Drozda JP; Ferguson TB; Jneid H; Krumholz HM; Nallamothu BK; Olin JW; Ting HH; ; Heidenreich PA; Albert NM; Chan PS; Curtis LH; Ferguson TB; Fonarow GC; Ho PM; O'Brien S; Russo AM; Thomas RJ; Ting HH; Varosy PD
    Circ Cardiovasc Qual Outcomes; 2016 Jan; 9(1):68-95. PubMed ID: 26666514
    [No Abstract]   [Full Text] [Related]  

  • 32. [Spanish interdisciplinary committee for cardiovascular disease prevention and the spanish society of cardiology position statement on dyslipidemia management. Differences between the European and american guidelines].
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
    Semergen; 2015 Apr; 41(3):149-57. PubMed ID: 25450438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicare Formulary Changes After the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline.
    Dhruva SS; Desai NR; Karaca-Mandic P; Shah ND; Ross JS
    J Am Coll Cardiol; 2017 Jan; 69(2):244-246. PubMed ID: 28081832
    [No Abstract]   [Full Text] [Related]  

  • 34. Translating AHA/ACC cholesterol guidelines into meaningful risk reduction.
    Wójcik C; Shapiro MD
    J Fam Pract; 2019 May; 68(4):206;210;212;214;217;221B. PubMed ID: 31226173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components.
    Virani SS
    Tex Heart Inst J; 2016 Aug; 43(4):313-4. PubMed ID: 27547139
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of Transatlantic Approaches to Lipid Management: The AHA/ACC/Multisociety Guidelines vs the ESC/EAS Guidelines.
    Singh M; McEvoy JW; Khan SU; Wood DA; Graham IM; Blumenthal RS; Mishra AK; Michos ED
    Mayo Clin Proc; 2020 May; 95(5):998-1014. PubMed ID: 32370858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012.
    Wong ND; Young D; Zhao Y; Nguyen H; Caballes J; Khan I; Sanchez RJ
    J Clin Lipidol; 2016; 10(5):1109-18. PubMed ID: 27678427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
    Okerson T; Patel J; DiMario S; Burton T; Seare J; Harrison DJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Nasir K; Bittencourt MS; Blaha MJ; Blankstein R; Agatson AS; Rivera JJ; Miedema MD; Sibley CT; Shaw LJ; Blumenthal RS; Budoff MJ; Krumholz HM
    J Am Coll Cardiol; 2015 Oct; 66(15):1657-68. PubMed ID: 26449135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study.
    Mortensen MB; Fuster V; Muntendam P; Mehran R; Baber U; Sartori S; Falk E
    J Am Coll Cardiol; 2016 Aug; 68(9):881-91. PubMed ID: 27561760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.